Tatu, Rukkaya E.

HRN: 23-58-11  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
CEFUROXIME 500MG (TAB)
08/28/2023
09/04/2023
PO
500mg
BID X 7 Days
2nd Degree RMLE And Repair
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: